Clearmind Medicine Files Patent in South Korea for MEAI in Depression Treatment

Patent expands MEAI’s global intellectual property protection as Clearmind advances clinical development and commercialization plans Clearmind Med...

November 06, 2025 | Thursday | News
CARsgen Reports Promising Early Clinical Data for Allogeneic CAR-T Candidates CT0596 and CT1190B in Multiple Myeloma and Lymphoma

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for...

November 04, 2025 | Tuesday | Reports
Sanyou Biopharmaceuticals and Shanghai ZJ Bio-Tech Forge Strategic Partnership to Automate Innovative Biologics Development

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Shanghai ZJ Bio-Tech technology Co., Ltd. (hereinafter refer...

November 04, 2025 | Tuesday | News
Samsung Bioepis to Assume Full Commercial Control of BYOOVIZ in Europe by January 2026

  Samsung Bioepis will assume full commercial responsibility for BYOOVIZ®(ranibizumab) upon full transition of Biogen’s commercializa...

October 30, 2025 | Thursday | News
Syncell Launches Synlight-Pure Kit to Enable 25 nm Precision Subcellular Proteomic Discovery

New Synlight-Pure™ Kit together with Syncell’s Microscoop® Mint platform achieves high-specificity subcellular proteomic discovery with 25 ...

October 30, 2025 | Thursday | News
bioAffinity Technologies Secures Australian Patent Expanding Global Lung Health Portfolio

Australian patent strengthens global patent portfolio -bioAffinity Technologies, Inc. a biotechnology company advancing early-stage diagnostic...

October 30, 2025 | Thursday | News
SK pharmteco Invests $6.1 Million to Expand U.S. Peptide Manufacturing Capabilities in California

SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facili...

October 24, 2025 | Friday | News
Syngene Strengthens India’s Biologics Leadership with New GMP Bioconjugation Suite in Bengaluru

Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commerci...

October 23, 2025 | Thursday | News
Agarose Bead Technologies Marks 25 Years with $10 Million Expansion and Global Growth Strategy

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins has announced plans for further expansion, reinforcing its positio...

October 22, 2025 | Wednesday | News
Rani Therapeutics Enters $1 Billion Collaboration with Chugai for Oral Biologics Development

Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up to $10...

October 20, 2025 | Monday | News
Building Biopharma Resilience — Cytiva’s Pierre-Alain Ruffieux on Balancing Progress and Preparedness

Resilience is no longer a corporate slogan — it’s the new currency of survival in biopharma. As the sector races between scientific breakthroug...

October 20, 2025 | Monday | Interaction
China NMPA Accepts Belite Bio’s NDA for Tinlarebant with Priority Review Based on Phase 3 DRAGON Interim Data

NMPA’s response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025  Belite Bio, Inc. (NASDAQ...

October 16, 2025 | Thursday | News
Forlong Biotechnology Receives First Milestone Payment for Fbody®-Based Fusion Protein Therapy Following IND Submission in China

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, to...

October 15, 2025 | Wednesday | News
Nasus Pharma Partners with Aptar to Advance Intranasal Epinephrine NS002 Toward Commercialization

Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the developm...

October 13, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close